Mupirocin Infectopharm (Mupirocin)

Mupirocin is an antibacterial agent used to address bacterial colonisation in the nasal cavity.

• Nasal colonisation of Staphylococcus aureus: reduces bacterial load and helps eradicate carriage.
• Prevention of Staphylococcal infections: decreases the risk of infection in individuals prone to staphylococcal disease.

• Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, a key enzyme required for incorporation of isoleucine into nascent proteins. By blocking this step, the drug halts bacterial protein synthesis, leading to a bacteriostatic effect at low concentrations and bactericidal activity at higher concentrations against susceptible Gram‑positive organisms.

Mupirocin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nasal irritation: mild burning or stinging sensation.
• Nasal itching: pruritus at the application site.
• Dryness of nasal mucosa.
• Sneezing or mild rhinorrhoea.
• Headache: transient and mild.
• Local erythema: redness of the nasal lining.

Serious or Rare Side Effects

• Allergic reaction: rash, urticaria, or angioedema.
• Anaphylaxis: severe, potentially life‑threatening hypersensitivity.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Contact dermatitis: persistent inflammation at the site.
• Systemic infection: rare bacteremia from compromised mucosa.
• Severe mucosal ulceration.

Before using Mupirocin Infectopharm, consider the following safety measures.

• Pregnancy: consult a prescriber; safety data are limited.
• Breastfeeding: discuss with a healthcare professional before use.
• Known hypersensitivity: avoid if allergic to mupirocin or other topical antibiotics.
• Concurrent nasal surgery or trauma: postpone application until healing.
• Use only as directed: do not exceed prescribed duration or frequency.
• Store at room temperature: keep in the original packaging, protect from moisture and light.

Mupirocin has a low potential for systemic drug interactions, but certain combinations may require attention.

Major Interactions (Avoid)

• Concurrent use of other topical antibiotics: may increase risk of bacterial resistance.
• Use with nasal decongestants containing vasoconstrictors: can exacerbate local irritation.

Moderate Interactions (Monitor Closely)

• Systemic antibiotics: may alter normal flora and affect colonisation dynamics.
• Antifungal nasal agents: potential for additive mucosal irritation.
• Immunosuppressive therapy: monitor for reduced local antibacterial efficacy.
• Chronic steroid nasal sprays: may increase risk of secondary infection.
• Use with nasal antihistamines: observe for enhanced dryness.